[The significance of IGF-1, VEGF, IL-6 in multiple myeloma progression]
- PMID: 16875552
[The significance of IGF-1, VEGF, IL-6 in multiple myeloma progression]
Abstract
Objective: To study the alteration and significance of IL-6, vascular endothelial growth factor (VEGF), insulin-like growth factor-1 (IGF-1) in MM progression and the interaction between the three cytokines.
Methods: Bone marrow samples from 28 patients with multiple myeloma (MM) (evolution group and steady group), 10 iron deficiency anemia (as normal control) and 2 monoclonal gammopathy of undetermined significance (MGUS) were studied. Bone marrow stromal cells (BMSCs) were established from the bone marrow MNCs. ELISA was performed to detect the concentration of IL-6, VEGF, IGF-1 in culture supernates.
Results: (1) The levels of IL-6 and VEGF secreted by BMSCs were increased in an order from normal control to steady group to evolution group (P < 0.05). However, the concentration of IGF-1 did not increase in MM patients (P > 0.05). (2) The levels of IL-6, VEGF and IGF-1 in the coculture supernates of U266 and BMSCs were increased significantly (P < 0.05), being in an ascending order from normal control to steady group to evolution group (P < 0.05). (3) BMSCs stimulated by exogenous IL-6, VEGF or IGF-1, secreted more VEGF, IGF-1/IL-6, IGF-1/VEGF, IL-6 than unstimulated (P < 0.05). (4) The levels of IL-6, VEGF, IGF-1 secreted by BMSCs from MGUS were similar to that from control group.
Conclusions: IL-6, VEGF, IGF-1 levels associate with evolution of MM; IL-6, VEGF and IGF-1 induce an increase in cytokines secretion of BMSCs.
Similar articles
-
[The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma].Zhonghua Nei Ke Za Zhi. 2005 Feb;44(2):85-8. Zhonghua Nei Ke Za Zhi. 2005. PMID: 15840215 Chinese.
-
[Clinical significance of serum vascular endothelial growth factor and interleukin-6 in multiple myeloma].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005 Feb;30(1):68-71. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005. PMID: 15871192 Chinese.
-
MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.Clin Cancer Res. 2006 Oct 1;12(19):5887-94. doi: 10.1158/1078-0432.CCR-05-2501. Clin Cancer Res. 2006. PMID: 17020997
-
Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.Stem Cells. 1995 Aug;13 Suppl 2:10-21. Stem Cells. 1995. PMID: 8520496 Review.
-
Cytokines and signal transduction.Best Pract Res Clin Haematol. 2005;18(4):509-24. doi: 10.1016/j.beha.2005.01.003. Best Pract Res Clin Haematol. 2005. PMID: 16026734 Review.
Cited by
-
Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization.J Hematol Oncol. 2014 Jan 15;7:9. doi: 10.1186/1756-8722-7-9. J Hematol Oncol. 2014. PMID: 24428908 Free PMC article.
-
Inhibition of IGF-1 signalling enhances the apoptotic effect of AS602868, an IKK2 inhibitor, in multiple myeloma cell lines.PLoS One. 2011;6(7):e22641. doi: 10.1371/journal.pone.0022641. Epub 2011 Jul 25. PLoS One. 2011. PMID: 21799925 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous